NCT06690775 2025-12-23CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.TORL Biotherapeutics, LLCPhase 2 Recruiting230 enrolled
NCT07064018 2025-07-14Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesUniversity of California, IrvinePhase 1/2 Recruiting67 enrolled